536 related articles for article (PubMed ID: 28844116)
1. Cardiometabolic Disorders in Psoriatic Disease.
Sobchak C; Eder L
Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
Puig L
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
[TBL] [Abstract][Full Text] [Related]
4. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting.
Boehncke WH
J Rheumatol; 2012 Feb; 39(2):441-4. PubMed ID: 22298277
[TBL] [Abstract][Full Text] [Related]
6. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
Yim KM; Armstrong AW
Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis: a skin disease associated with increased cardiovascular risk.
González-Gay MA; González-Vela C; González-Juanatey C
Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives.
Kapniari E; Papadimitriou P; Dalamaga M; Makavos G; Piaserico S; Egeberg A; Ikonomidis I; Papadavid E
Curr Vasc Pharmacol; 2020; 18(6):592-609. PubMed ID: 32445456
[TBL] [Abstract][Full Text] [Related]
9. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
[TBL] [Abstract][Full Text] [Related]
10. [Comorbidity in connection with psoriasis is more than psoriatic arthritis].
Kvist-Hansen A; Kaiser H; Skov L; Hansen PR
Ugeskr Laeger; 2018 Jan; 180(2):. PubMed ID: 29368688
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis and cardiovascular disorders.
Frieder J; Ryan C
G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
[TBL] [Abstract][Full Text] [Related]
12. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
[TBL] [Abstract][Full Text] [Related]
13. The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities?
Lotti T; Hercogova J; Prignano F
Dermatol Ther; 2010; 23(2):119-22. PubMed ID: 20415818
[TBL] [Abstract][Full Text] [Related]
14. Metabolic comorbidities and psoriasis.
Gisondi P; Ferrazzi A; Girolomoni G
Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
Boehncke WH; Gladman DD; Chandran V
J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory arthritis as a novel risk factor for cardiovascular disease.
John H; Kitas G
Eur J Intern Med; 2012 Oct; 23(7):575-9. PubMed ID: 22841864
[TBL] [Abstract][Full Text] [Related]
19. Polyarticular evolution and late-onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis.
Queiro R; Lorenzo A; Tejón P; Pardo E; Coto P; Ballina J
Int J Rheum Dis; 2019 Feb; 22(2):269-274. PubMed ID: 30398011
[TBL] [Abstract][Full Text] [Related]
20. Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
Colaco K; Lee KA; Akhtari S; Winer R; Welsh P; Sattar N; McInnes IB; Chandran V; Harvey P; Cook RJ; Gladman DD; Piguet V; Eder L
Ann Rheum Dis; 2021 Nov; 80(11):1429-1435. PubMed ID: 34049856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
